
0.6899 Delayed Data As of May 27 | ![]() Today’s Change | 0.61 Today|||52-Week Range 7.24 | -74.54% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $104.7M |
Clovis Oncology, Inc. 5500 Flatiron Parkway Boulder Colorado 80301 |
Patrick J. Mahaffy | President, Chief Executive Officer & Director |
Daniel W. Muehl | Chief Financial Officer & Executive Vice President |
Lindsey Rolfe | Chief Medical Officer & Executive VP-Clinical |
Thomas Fuglsang Harding | Chief Scientific Officer & Executive VP |
Gillian C. Ivers-Read | Chief Regulatory Officer & Executive VP |